Article
The formyl peptide receptor 2 regulates microglial phenotype through immunometabolism : implications for Alzheimer's disease
2019-01-01
Abstract excerpt
Microglia are key players in the pathology of Alzheimer’s disease (AD), driving chronic inflammation, oxidative stress, and the altered metabolism seen in the brains of patients. With clinical trials continuing to fail, new approaches towards drug development are critical. Strategies to reduce microglial activation may therefore be a viable therapeutic approach to tackling AD. Formyl peptide receptor 2 (Fpr2), whi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b8228856-1ca2-5211-984e-ba8b5fe1a220
- DOI
- 10.34737/qy292
